Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Arbuckle Stuart A
Relationship:   Director
City:   Cambridge,
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   62,795    

Indirect Shares

  140      
Direct Value   $21,926,350    

Indirect Value

  $61,758      
Total Shares   62,935      
Total Value   $21,988,108      


Vertex Pharmaceuticals Inc
 $21,920,191 Dare Bioscience Inc
 $6,159 Vertex Pharmaceuticals Inc
 $21,920,191 Dare Bioscience Inc
 $6,159
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, COO 2024-05-15 49,691 2024-05-15 140    Premium*  
            Dare Bioscience Inc DARE Director 2017-01-03 13,104 2016-10-03 0    Premium*  
            Immunogen Inc IMGN Director 2024-02-12 0 2023-06-30 0    Premium*  
* Premium Members only  

Records found :    192         Free Registration Required For Full Results.    Limit: 25

Download
  Page 7 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2015-10-01 4 AS $102.30 $1,300,225 D/D (12,417) 115,098 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-02-17 4 D $292.85 $1,317,239 D/D (4,498) 71,107 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-17 4 D $211.75 $1,321,320 D/D (6,240) 55,460 0 -
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2014-10-01 4 AS $106.32 $1,337,377 D/D (12,417) 42,264 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-09 4 D $422.74 $1,343,045 D/D (3,177) 80,013 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-02-24 4 D $289.12 $1,362,912 D/D (4,714) 61,590 0 -
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2018-02-05 4 AS $163.08 $1,386,180 D/D (8,500) 41,952 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-20 4 D $420.58 $1,418,616 D/D (3,373) 67,846 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-02-27 4 AS $287.16 $1,447,143 D/D (5,034) 56,556 0 %
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-02-13 4 AS $296.44 $1,460,816 D/D (4,887) 82,003 0 %
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2018-01-24 4 AS $169.00 $1,515,761 D/D (8,969) 41,952 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-21 4 AS $421.77 $1,519,637 D/D (3,603) 59,439 0 %
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-12-13 4 OE $187.53 $1,613,321 D/D 8,603 65,159 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2022-02-24 4 D $227.86 $1,651,074 D/D (7,246) 65,066 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Commercial Officer   •       –      –    2021-02-18 4 AS $210.05 $1,657,481 D/D (7,825) 47,635 0 %
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2017-06-01 4 AS $124.00 $1,685,656 D/D (13,594) 131,467 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2022-08-09 4 AS $300.53 $1,710,817 D/D (5,690) 60,996 0 %
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-02-13 4 D $298.26 $1,786,577 D/D (5,990) 86,890 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-12 4 AS $420.24 $1,804,931 D/D (4,295) 75,718 0 %
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-16 4 D $424.01 $1,907,621 D/D (4,499) 71,219 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2023-02-14 4 AS $295.84 $1,910,962 D/D (6,398) 75,605 0 %
VRTX Vertex Pharmaceuticals In... EVPChief Commercial Officer   •       –      –    2017-07-21 4 AS $159.00 $2,011,271 D/D (12,475) 121,117 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-20 4 AS $420.79 $2,021,475 D/D (4,804) 63,042 0 %
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-23 4 D $431.79 $2,035,458 D/D (4,714) 54,725 0 -
VRTX Vertex Pharmaceuticals In... EVP, COO   •       –      –    2024-02-26 4 AS $425.70 $2,142,974 D/D (5,034) 49,691 0 %

  192  Records found
  1   2   3   4   5   6   7  8      
  Page 7 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed